Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring
- 1 April 1995
- journal article
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 6 (4) , 321-328
- https://doi.org/10.1097/00019501-199504000-00009
Abstract
The aim was to evaluate whether frequent analysis of creatine kinase MB (CK-MB), myoglobin and troponin T alone or in combination could either confirm or exclude acute myocardial infraction (AMI) within the first few hours after patients were admitted to hospital with chest pain and a non-diagnostic ECG. One hundred and forty-two patients with chest pain (< or = 12 h) and a non-diagnostic ECG were included in the study. Blood samples were obtained every 30 min during the first 3 h and thereafter at longer intervals. Different discriminatory levels and combinations of markers were tested for their ability to detect (n = 59) or exclude (n = 83) AMI during the first 6 h after admission. No single marker adequately combined high early sensitivity and specificity. However, a combination of myoglobin and CK-MB analyses had a sensitivity at entry of 59%, which increased by 5-10% every 30 min and reached 92% after 2 h and 98% after 6 h with a specificity of 93%. A combination of myoglobin and troponin T analyses showed identical sensitivity but a slightly inferior specificity. In the patients with no AMI it was possible to exclude AMI in 64% within 3 h by using myoglobin and within 6 h in approximately 70% by using CK-MB or troponin T. Monitoring of a combination of myoglobin and CK-MB or troponin T will allow confirmation or exclusion of AMI within 3-6 h in almost all patients. This method will have a large impact on the handling of patients with suspected AMI without a diagnostic ECG.Keywords
This publication has 0 references indexed in Scilit: